Search Results

Displaying Results 2201-2225 of 3268 "'EYE'"

Jan 28, 2026, 09:00 ET Michelob ULTRA & Kurt Russell Ignite America's Competitive Spirit in New Super Bowl LX Commercial

competitive edge and outplay his friends when Michelob ULTRA is at stake. As Pullman levels up on the ski slopes, to the soundtrack of Survivor's The Eye of the Tiger, he surprises even the most elite athletes, proving anyone can rise to the moment when there's something worth playing for.Rooted

More news about: Michelob ULTRA


Jan 28, 2026, 08:45 ET Half of US Companies Brace for a Turnover Surge in 2026 -- and the Price Tag Just Hit $45,236 Per Employee

years. A new Express Employment Professionals-Harris Poll survey shows turnover expectations jumped from 39% in fall 2024 and 33% in fall 2023 to an eye‑catching 50% in 2026.

More news about: Express Services dba Express Employment Professionals


Jan 28, 2026, 08:44 ET Apera AI Accelerates 4D Vision Deployments with Launch of Apera Vue 9.52 and 4X Faster Apera Forge AI Training

results, even with unstructured and shifting racks. This feature is designed for use with Eye-in-Hand (EOAT-mounted) VuePort XS cameras.Robot Mechanical Error Histogram When running hand-eye calibration, Vue 9.52 now provides a histogram displaying any robot mechanical (intrinsic)

More news about: Apera AI Inc.


Jan 28, 2026, 08:15 ET Skin Boosters Market to Surpass USD 3,263.80 Million by 2032, Shows New Analysis on Injectable Skin Rejuvenation and Anti-Aging Trends: MMR Statistics

Leading dermatology clinics worldwide are elevating anti-aging treatments for women, delivering visibly hydrated, youthful skin. From under-eye revitalization to full-face rejuvenation, advanced injectable skin rejuvenation treatments are redefining beauty standards, blending science,

More news about: Maximize Market Research Pvt. Ltd.


Jan 28, 2026, 08:00 ET Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine

the target muscle(s).Dry Eye in Patients Treated With BOTOX® CosmeticThere have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual

More news about: AbbVie


Jan 28, 2026, 06:08 ET Stellular Bio Announces Closing of Series 1 Financing

clinical testing as a treatment for Sjogren's disease dry eye.Sjogren's disease (SjD) is a complex multisystem autoimmune disorder affecting roughly 4 million patients in the United States alone.1 75 percent of SjD patients say the eye dryness and irritation that is a hallmark of the disease

More news about: Stellular Bio


Jan 28, 2026, 05:00 ET More than 130,000 Individuals Register to Save Lives Through MyChart Donor Registration Initiative

2026 /PRNewswire/ -- Donate Life America (DLA) announced today that more than 130,000 people have registered their decision to become organ, eye and tissue donors through MyChart, the nation's most widely used patient portal. DLA began its close collaboration with Epic— the global healthcare software

More news about: Donate Life America


Jan 27, 2026, 21:00 ET Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

SNEC.About Singapore Eye Research Institute Established in 1997 as Singapore's national research institute for ophthalmic and vision research, the Singapore Eye Research Institute's (SERI) mission is to conduct high-impact eye research that prevents blindness, low vision and major eye diseases common

More news about: Singapore National Eye Centre; Singapore Eye Research Institute


Jan 27, 2026, 14:05 ET Anchor Line Partners Supports Stoke Therapeutics' Growth by Securing a 98,500 Square-Foot Lease in Waltham, MA

patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and

More news about: Anchor Line Partners


Jan 27, 2026, 13:57 ET Lamborghini Charlotte Showcases the 2022 Lamborghini Huracán STO

the Huracán STO offers razor-sharp handling and an immersive driving experience.Striking Design in Verde Scandal MetallicFinished in an eye-catching Verde Scandal Metallic paint, this Huracán STO commands attention from every angle. Its aggressive aerodynamics are highlighted by a bold rear

More news about: Lamborghini Charlotte


Jan 27, 2026, 12:45 ET An InventHelp 123Invent Client Develops Improved Towel Product for Fitness Enthusiasts (ADA-2083)

that may accumulate on exercise equipment. It also prevents the towel from falling onto the floor. As a result, it increases sanitary conditions and convenience. The invention features a portable and eye-catching design that is easy to apply and use so it is ideal for gym and home fitness equipment.Additionally, using disinfectant cleaners and

More news about: InventHelp


Jan 27, 2026, 11:15 ET InventHelp Inventor Develops New Bowling Ball Thumb Insert (TKC-104)

doing so, it offers an eye-catching alternative to conventional bowling ball thumb inserts. As a result, it allows the user to express interests, hobbies, support for a favorite sports team, etc. It also enhances performance among bowlers. The invention features a stylish and eye-catching appearance that

More news about: InventHelp


Jan 27, 2026, 11:00 ET Donor Network West Strengthens Executive Leadership Team with E'Tiffany Jones as Vice President of Communications, Marketing & Community Engagement

federally-designated organ procurement organization for northern California and northern Nevada, Donor Network West saves and heals lives through organ, eye, and tissue donation and transplantation.

More news about: Donor Network West


Jan 27, 2026, 10:45 ET Global Wellness Institute Unveils New Data on the Wellness Markets of 145 Countries

as in 2019—catapulted the country up six places in the rankings, to become the 26th largest global market. Smaller wellness markets with eye-opening recent growth include Croatia, Cuba, Romania, Costa Rica and Kazakhstan—all growing over 9% annually since 2019. The nations with the weakest

More news about: GLOBAL WELLNESS INSTITUTE


Jan 27, 2026, 10:41 ET Finding each other through the algorithm: one year as a 'local' on China's social media: Global Times

WeChat, chatting face-to-face online, meeting family members from both our families, and sharing our personal lives and culture. It has been really eye-opening.Since a year ago, my understanding of China and its people has improved. I have found close friends, seen more of the culture, gained more

More news about: Global Times


Jan 27, 2026, 09:30 ET February is Age-related Macular Degeneration (AMD) and Low Vision Month at Prevent Blindness, Designed to Provide Helpful Sight-saving Resources and Support Programs

GuideMe app. This resource provides a customized overview of AMD along with a tailored resource list and suggested steps to help save sight from the eye disease specific to the individual using the GuideMe app. Prevent Blindness offers additional educational resources including

More news about: Prevent Blindness


Jan 27, 2026, 09:00 ET BTL Reports Global Revenue Exceeding $850 Million and Signals Accelerating Growth in North America for 2026

across core application areas.As part of its 2026 initiatives, BTL announced that it has received regulatory clearance in Canada for its dry eye treatment solution, marking entry into ophthalmology as a new specialty segment within the North American market. In parallel, 2026 also marks the commercial

More news about: BTL


Jan 27, 2026, 08:29 ET /C O R R E C T I O N -- Orasis Pharmaceuticals/

[email protected]:1 Manns F, Cabot F, Ruggeri M. ORASIS–Bascom Palmer Eye Institute Study: Effect of pilocarpine eye drops on ciliary muscle accommodative response; revised analysis by Gerard Smits. Presented at Hawaiian Eye & Retina 2026; January 17-23, 2026; Waikoloa Village, HI.2

More news about: Orasis Pharmaceuticals


Jan 27, 2026, 08:05 ET EMPAVA Returns to KBIS 2026 with Sculptura Bath Design and Live Mermaid Activation

performance-driven recovery into the home through a clean, purpose-built approach to modern wellness.Iridescent Blue Diamond Tub: This eye-catching tub boasts a blue diamond finish, beautifully designed to stand out in any bathroom, 28 powerful massaging and bubble jets, and a spacious 49.2-inch

More news about: EMPAVA


Jan 27, 2026, 05:21 ET Xinhua Silk Road: Indices unveiled for industry players to take pulse of global shipping, commodity markets in E China

capacities and integrated development of ports, industries and cities.For instance, the port cluster of Shandong ranked among the first tier given its eye-catching production capacity, support from port hinterlands, operation capability, high-quality development, coordinated development and comprehensive

More news about: Xinhua Silk Road


Jan 27, 2026, 05:10 ET Xinhua Silk Road: Indices unveiled for industry players to take pulse of global shipping, commodity markets in E China

capacities and integrated development of ports, industries and cities.For instance, the port cluster of Shandong ranked among the first tier given its eye-catching production capacity, support from port hinterlands, operation capability, high-quality development, coordinated development and comprehensive

More news about: Xinhua Silk Road


Jan 27, 2026, 04:20 ET Mandira Bedi Shares Her Journey of Resilience, Discipline and Reinvention on the New Episode of Herbalife India's Podcast Live Your Best Life, Unscripted

Reinventing Body, Mind & Life," the episode explores Mandira Bedi's journey through personal loss, single parenthood, a multi-decade career in the public eye, and her unwavering commitment to discipline, movement and self-belief.Mandira opens up about navigating grief with honesty, allowing herself

More news about: Herbalife India


Jan 27, 2026, 03:00 ET Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

forces with IDEAYA Biosciences to make Darovasertib available to patients. This is a potential treatment for uveal melanoma, which is a rare type of eye cancer.Featuring in the Top 10 of the PatientView Survey[3] and obtaining the leading position in the oncology category

More news about: Servier


Jan 27, 2026, 03:00 ET Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

forces with IDEAYA Biosciences to make Darovasertib available to patients. This is a potential treatment for uveal melanoma, which is a rare type of eye cancer.Featuring in the Top 10 of the PatientView Survey[3] and obtaining the leading position in the oncology category

More news about: Servier


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.